Kohn M , Portier C.Effects of the mechanism of receptor-mediated gene expression on the shape of the dose-response curve . Risk Analysis1993; 13: 565-572 .
2.
Lusteret al.Risk assessment in immunotoxicology. II: Relationships between immune and host resistance tests . Fundamental and Applied Toxicology1993; 21: 71-82 .
3.
Bogen K.Mechanistic model predicts a U-shaped relation of radon exposure to lung cancer risk reflected in combined occupational and U.S. residential data . BELLE Newsletter, 1998 (current issue).
4.
Andersen M , Conolly R.Mechanistic modeling of rodent liver tumor promotion at low levels of exposure: an example related to dose-response relationships for 2,3,7,8-tetrachlorodibenzo-p-dioxin . BELLE Newsletter, 1998 (current issue).
5.
Downs T , Frankowski R.A cancer risk model with adaptive repair . BELLE Newsletter, 1998 (current issue).
6.
Portier C.Risk ranges for various endpoints following exposure to 2,3,7,8-TCDD. In WHOECEH/IPCS Consultation On Assessment Of The Health Risk Of Dioxins; Re-Evaluation Of The Tolerable Daily Intake, World Health Organization, Geneva, Switzerland1998.
7.
Portier CJet al.Modeling the number and size of hepatic focal lesions following exposure to 2,3,7,8- TCDD . Toxicology and Applied Pharmacology1996; 138: 20-30 .
8.
Sherman CD , Portier CJ.The multipath/multistage model of carcinogenesis . Informatik Biometrie und Epidemiologie in Medizin und Biologie1994; 25: 250-254 .
9.
Sherman C , Portier C.The two-stage model of carcinogenesis: overcoming the nonidentifiability dilemma . Risk Analysis1997; 17: 367-374 .
10.
Jirtle RL , Meyer SA.Liver tumor promotion -effect of phenobarbital on EGF and protein-kinase-C signal transduction and transforming growth factor-beta 1 expression . Digestive Diseases and Science1991; 36(5): 659-668 .
